|
|
Boston Scientific Corporation (BSX) |
|
|
|
| |
BSX's Revenue Growth by Quarter and Year
Boston Scientific's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BSX Revenue (in millions $) |
FY 2024 |
FY 2023 |
FY 2022 |
FY 2021 |
| IV Quarter |
December |
-
|
3,725.00
|
3,243.00
|
3,127.00
|
| III Quarter |
September |
-
|
3,527.00
|
3,170.00
|
2,932.00
|
| II Quarter |
June |
4,120.00
|
3,600.00
|
3,244.00
|
3,077.00
|
| I Quarter |
March |
3,857.00
|
3,389.00
|
3,026.00
|
2,752.00
|
| FY |
|
7,977.00
|
14,241.00
|
12,683.00
|
11,888.00
|
| BSX Revenue second quarter 2024 Y/Y Growth Comment |
Boston Scientific Corporation achieved in the second quarter 2024, above Company average Revenue increase of 14.44% year on year, to $ 4,120.00 millions.
Looking into second quarter 2024 results within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue growth. While Boston Scientific Corporation' s Revenue growth of 14.44% ranks overall at the positon no. 360 in the second quarter 2024.
|
| BSX Revenue ( Y/Y Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
14.86 % |
3.71 % |
15.47 % |
| III Quarter |
September |
- |
11.26 % |
8.12 % |
10.27 % |
| II Quarter |
June |
14.44 % |
10.97 % |
5.43 % |
53.62 % |
| I Quarter |
March |
13.81 % |
12 % |
9.96 % |
8.22 % |
| FY |
|
- |
12.28 % |
6.69 % |
19.92 % |
BSX Revenue (Quarter on Quarter Growth %) |
2024
|
2023 |
2022 |
2021 |
| IV Quarter |
December |
- |
5.61 % |
2.3 % |
6.65 % |
| III Quarter |
September |
- |
-2.03 % |
-2.28 % |
-4.71 % |
| II Quarter |
June |
6.82 % |
6.23 % |
7.2 % |
11.81 % |
| I Quarter |
March |
3.54 % |
4.5 % |
-3.23 % |
1.62 % |
| FY (Year on Year) |
|
- |
12.28 % |
6.69 % |
19.92 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 110.61 % |
7.41 % |
-49.83 % |
| (Dec 31 2019) |
|
(Dec 31 2020) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 110.61 % |
7.41 % |
-49.83 % |
| (Dec 31 2019) |
|
(Dec 31 2020) |
|
| Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024 |
Boston Scientific's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 99.41 % |
2.73 % |
-52.89 % |
| (Dec 31 2019) |
|
|
| BSX's II. Quarter Q/Q Revenue Comment |
Boston Scientific Corporation achieved in the II. Quarter 2024 above company average sequential Revenue increase of 6.82%, to $ 4,120.00 millions, from $3,857.00 millions in the first quarter.
Boston Scientific is undergoing a remarkable growth, not just claiming above normal increase, and also accelerating pace.
Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 336. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 99.41 % |
2.73 % |
-52.89 % |
| (Dec 31 2019) |
|
|
| BSX's II. Quarter Q/Q Revenue Comment |
Boston Scientific Corporation achieved in the II. Quarter 2024 above company average sequential Revenue increase of 6.82%, to $ 4,120.00 millions, from $3,857.00 millions in the first quarter.
Boston Scientific is impressively improving, with claiming better then average gain, and additionally accelerating rate.
Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 336. |
|
Boston Scientific's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
12 Months Ending
(Dec 31 2023) |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
| Cumulative Revenue 12 Months Ending |
$ 15,229.00 |
$ 14,709.00 |
$ 14,241.00 |
$ 13,759.00 |
$ 13,402.00 |
| Y / Y Revenue Growth (TTM) |
13.63 % |
12.75 % |
12.28 % |
9.49 % |
8.7 % |
| Year on Year Revenue Growth Overall
Ranking |
# 926 |
# 388 |
# 450 |
# 1386 |
# 703 |
| Seqeuential Revenue Change (TTM) |
3.54 % |
3.29 % |
3.5 % |
2.66 % |
2.73 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 1332 |
# 539 |
# 626 |
# 2040 |
# 951 |
| Cumulative Revenue growth
Comment |
Boston Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 13.63% year on year, to $ 15,229 millions if the fiscal year would have ended in Jun 30 2024.
Boston Scientific's trailing twelve months Revenue growth was higher than company's average 6.63% and higher than 12.75% growth in Mar 31 2024.
But from twelve months ended Mar 31 2024 increase was beneth at 3.54 % from $14709 millions achieved in the period from Mar 31 2024 to Jun 30 2023 Andre Gonçalves added on.
It appears to be drop-off developing, more obvious if you pay attention to the typical Q/Q TTM Revenue advancement what is higher at 6.63%.
The growth was even stronger from twelve months ended Mar 31 2024 clinched at 3.54 % rise from $14709 millions in twelve months ending a quarter Mar 31 2024.
In the Healthcare sector 173 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 388 to 926. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.63 % |
-25.46 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.63 % |
-25.46 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 72 |
| Sector |
# 217 |
| S&P 500 |
# 1332 |
|
| Cumulative Revenue growth
Comment |
Boston Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 13.63% year on year, to $ 15,229 millions if the fiscal year would have ended in Jun 30 2024.
Boston Scientific's trailing twelve months Revenue growth was higher than company's average 6.63% and higher than 12.75% growth in Mar 31 2024.
But from twelve months ended Mar 31 2024 increase was slower at 3.54 % from $14709 millions recorded in the period from Mar 31 2024 to Jun 30 2023.
It appears to be stagnation in progress, more noticeable as we look at usual Q/Q TTM Revenue advancement which is higher at 6.63% Andre Gonçalves noted.
The growth is even stronger sequentially clinched at 3.54 % rise from $14709 millions in twelve months ending a quarter Mar 31 2024.
In the Healthcare sector 173 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 388 to 926. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.63 % |
-25.46 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.63 % |
-25.46 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 72 |
| Sector |
# 217 |
| S&P 500 |
# 1332 |
|
24.69%